This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Tumor Metabolism and the Microenvironment - VIRTUAL CONTENT AVAILABLE ON DEMAND
joint with Integrating Metabolism and Immunity - VIRTUAL CONTENT AVAILABLE ON DEMAND
Organizer(s): Erik A. Sahai, Alec Kimmelman and Johanna A. Joyce
Date: January 25 - 28, 2021
Location: Virtual at your computer. Recorded presentation content is available On Demand.
Sponsored by AstraZeneca, Cell Research and Gilead Sciences, Inc.
For important information on the coronavirus, please click here
Summary of Meeting:
As we know, cancer is a major cause of mortality worldwide. Furthermore, cancers result from mutations within somatic cells; however, their evolution and phenotype are determined by their environment, both local and systemic. Increased understanding of mechanisms that drive cancer will provide new avenues to reduce incidence and to treat the disease. Therefore, this meeting brings together researchers focusing on how nutrient availability and utilization influences tumors and those thinking about the multitude of inter-cellular interactions occurring within tumors. The inter-connections between these fields are becoming ever more apparent and this meeting unites the fields of tumor metabolism and the tumor microenvironment together, sparking new synergies and connectivity between researchers. With the extensive opportunities for discussion and numerous short talk slots on the program, this conference will help nurture early career scientists, the next generation of talent, and lead to the emergence of collaborative networks. Moreover, there is an afternoon workshop on “Transitioning to Independence” for early career researchers. Finally, a thorough understanding of how tumor systems can adapt and re-wire in response to challenges is needed to ensure that new therapies being developed have the best chance of success as they enter clinical trials. To that end, several speakers have been selected with the expectation that they discuss either clinical trial data. This will strengthen the linkage between cutting-edge mechanistic studies and human disease.
Scholarship Deadline: November 1 2020
Abstract Deadline: December 14 2020
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
AstraZenecaCell ResearchGilead Sciences, Inc.
We gratefully acknowledge additional support from these exhibitors at this conference:
Don Whitley Scientific LimitedHypOxygen
We gratefully acknowledge additional support for this conference from:
American Association for Cancer Research (AACR)DCVC BioNanoString Technologies, Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA254450-01
Funding for this conference was made possible (in part) by 1R13CA254450-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found